About
Diagnosis of Cognitive Disorders
Areas of Focus
Categories
DiagnosticsNJ, NY, PA
Team (3)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
710
By Phase
PHASE2: 4PHASE1: 1
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
Today
Hover over trial bars to see details
Recent Trials
NCT00738595Lead Sponsor
Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
PHASE2Completed
400 participants
Started: Aug 31, 2008 · Completed: May 31, 2009
NCT00622752Lead Sponsor
Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes
PHASE2Completed
90 participants
Started: Feb 29, 2008 · Completed: May 31, 2008
NCT00526968Lead Sponsor
The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function
PHASE1Completed
19 participants
Started: Sep 30, 2007 · Completed: Dec 31, 2007
NCT00401284Lead Sponsor
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
PHASE2Completed
135 participants
Started: Nov 30, 2006 · Completed: Jul 31, 2007
NCT00380003Lead Sponsor
Efficacy Study of EVT 201 to Treat Insomnia
PHASE2Completed
66 participants
Started: Sep 30, 2006 · Completed: Apr 30, 2007
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...